Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Abstract Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first‐ and second‐generation TKIs, third‐generation inhibitors, incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Fan Chen, Jinpeng Liu, Robert M. Flight, Kassandra J. Naughton, Alexsandr Lukyanchuk, Abigail R. Edgin, Xiulong Song, Haikuo Zhang, Kwok‐Kin Wong, Hunter N. B. Moseley, Chi Wang, Christine F. Brainson
Format: article
Language:EN
Published: Wiley 2021
Subjects:
alveolar
bronchiolar
EGFR
lung cancer
organoids
Science
Q
Online Access:https://doaj.org/article/1d70799b294842b6a8cf3f7bd6a3471b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/1d70799b294842b6a8cf3f7bd6a3471b

Similar Items